Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$655M |
| 2 |
Coty
COTY
|
+$380M |
| 3 |
ConocoPhillips
COP
|
+$250M |
| 4 |
Zimmer Biomet
ZBH
|
+$213M |
| 5 |
Valero Energy
VLO
|
+$170M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$523M |
| 2 |
Merck
MRK
|
+$375M |
| 3 |
SHPG
Shire pic
SHPG
|
+$362M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$310M |
| 5 |
CELG
Celgene Corp
CELG
|
+$286M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.57% |
| 2 | Technology | 12.05% |
| 3 | Financials | 10.74% |
| 4 | Consumer Discretionary | 9.44% |
| 5 | Energy | 8.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GTYH
3801
DELISTED
GTY Technology Holdings, Inc. Common Stock
GTYH
| $118K | ﹤0.01% |
13,407
-10,108
| -43% | -$95.3K |
|
3802
Spyre Therapeutics
SYRE
$9.47B
| $117K | ﹤0.01% |
581
-254
| -30% | -$52.9K |
|
3803
J. Jill
JILL
$305M
| $116K | ﹤0.01% |
+4,219
| New | +$108K |
|
3804
LG Display
LPL
$3.31B
| $116K | ﹤0.01% |
+13,391
| New | +$119K |
|
3805
Vertiv
VRT
$98B
| $116K | ﹤0.01% |
+11,560
| New | +$115K |
|
3806
NatWest
NWG
$74.4B
| $114K | ﹤0.01% |
+16,302
| New | +$114K |
|
|
AIOT
3807
PowerFleet Inc
AIOT
$404M
| $114K | ﹤0.01% |
+19,226
| New | +$120K |
|
3808
Microvision
MVIS
$53.8M
| $113K | ﹤0.01% |
7,770
-7,425
| -49% | -$108K |
|
3809
Senseonics Holdings Inc
SENS
$515M
| $113K | ﹤0.01% |
2,311
-930
| -29% | -$49.4K |
|
3810
Immersion
IMMR
$252M
| $112K | ﹤0.01% |
+13,229
| New | +$121K |
|
|
ZYNE
3811
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
| $112K | ﹤0.01% |
20,710
-9,894
| -32% | -$48.1K |
|
|
DSSI
3812
DELISTED
Diamond S Shipping Inc. Common Shares
DSSI
| $112K | ﹤0.01% |
+10,727
| New | +$115K |
|
|
EAD
3813
Allspring Income Opportunities Fund
EAD
$375M
| $107K | ﹤0.01% |
+13,574
| New | +$105K |
|
|
RMT
3814
Royce Micro-Cap Trust
RMT
$764M
| $107K | ﹤0.01% |
+12,896
| New | +$107K |
|
3815
Crawford & Co Class A
CRD.A
$647M
| $104K | ﹤0.01% |
+11,223
| New | +$108K |
|
|
SGMO
3816
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $104K | ﹤0.01% |
+10,882
| New | +$111K |
|
|
JCP
3817
DELISTED
J.C. Penney Company, Inc.
JCP
| $104K | ﹤0.01% |
69,683
-5,785
| -8% | -$8.15K |
|
3818
Vaalco Energy
EGY
$605M
| $103K | ﹤0.01% |
45,809
-12,811
| -22% | -$26.9K |
|
|
SELF
3819
Global Self Storage
SELF
$63.5M
| $103K | ﹤0.01% |
26,705
-3,378
| -11% | -$13.3K |
|
|
IVC
3820
CALL
DELISTED
Invacare Corporation
IVC
| $99K | ﹤0.01% |
+11,800
| New | +$85K |
|
3821
Lifeway Foods
LWAY
$408M
| $98K | ﹤0.01% |
40,432
-4,109
| -9% | -$9.76K |
|
|
HTT
3822
High Templar Tech Ltd
HTT
$391M
| $97K | ﹤0.01% |
+19,103
| New | +$102K |
|
3823
VirTra
VTSI
$35M
| $97K | ﹤0.01% |
24,276
-1,079
| -4% | -$4.24K |
|
|
EGLE
3824
DELISTED
Eagle Bulk Shipping Inc.
EGLE
| $96K | ﹤0.01% |
+2,943
| New | +$95.4K |
|
|
MGI
3825
DELISTED
MoneyGram International, Inc. New
MGI
| $94K | ﹤0.01% |
+46,215
| New | +$105K |
|
Similar funds
Israel Englander's Q1 2019 Portfolio in Review
As of Q1 2019, Israel Englander held 4,608 positions worth $66.8B, up 4.2% from $64.1B the previous quarter. Its ten largest holdings account for 7.1% of the portfolio.
Israel Englander withdrew a net $6.14B in Q1 2019, closing 675 positions and reducing 1,467 holdings. Its most notable exit was Merck, an estimated $375M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, down from 14% a quarter earlier, followed by Technology and Financials.
Against the trend, Israel Englander opened a new position in Zimmer Biomet worth $232M.
- Israel Englander's largest Q1 2019 buy was Zimmer Biomet: 1,870,503 shares worth $232M.
- Israel Englander added most to Walt Disney in Q1 2019, an estimated $655M increase.
- Israel Englander's biggest Q1 2019 reduction was Apple, cutting an estimated $523M.
- Israel Englander fully exited Merck in Q1 2019, selling an estimated $375M.
- Israel Englander's ten largest holdings make up 7.1% of its $66.8B portfolio in Q1 2019.
- Israel Englander opened 914 new positions and closed 675 in Q1 2019.
- Israel Englander's portfolio value rose 4.2% quarter-over-quarter to $66.8B.
Based on Millennium Management's 13F filing for Q1 2019, filed 14 May 2019.